{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:03Z","timestamp":1786994103194,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":249,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305839\/2015-2"],"award-info":[{"award-number":["305839\/2015-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["409928\/2016-0"],"award-info":[{"award-number":["409928\/2016-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.mehy.2020.109664","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T11:43:25Z","timestamp":1583322205000},"page":"109664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Controlled hypobaric hypoxia increases immunological tolerance by modifying HLA-G expression, a potential therapy to inflammatory diseases"],"prefix":"10.1016","volume":"140","author":[{"given":"Marina","family":"Ziliotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Marques","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Artur Bogo","family":"Chies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"407","key":"10.1016\/j.mehy.2020.109664_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/stke.4072007cm8","article-title":"Hypoxia-inducible factor 1 (HIF-1) pathway","volume":"2007","author":"Semenza","year":"2007","journal-title":"Sci STKE"},{"issue":"5663","key":"10.1016\/j.mehy.2020.109664_b0010","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1126\/science.303.5663.1454","article-title":"How cells endure low oxygen","volume":"303","author":"Marx","year":"2004","journal-title":"Science (80-)"},{"issue":"4","key":"10.1016\/j.mehy.2020.109664_b0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/humupd\/dmp046","article-title":"Beyond oxygen: Complex regulation and activity of hypoxia inducible factors in pregnancy","volume":"16","author":"Pringle","year":"2009","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.mehy.2020.109664_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31100-6","article-title":"Selection scan reveals three new loci related to high altitude adaptation in Native Andeans","volume":"8","author":"Jacovas","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.mehy.2020.109664_b0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.mehy.2020.109664_b0030","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"83","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"issue":"3","key":"10.1016\/j.mehy.2020.109664_b0035","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1152\/physrev.00043.2017","article-title":"Gestational hypoxia and developmental plasticity","volume":"98","author":"Ducsay","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2020.109664_b0040","doi-asserted-by":"crossref","unstructured":"Imtiyaz HZ, Simon MC. Hypoxia-Inducible Factors as Essential Regulators of Inflammation. 2010;105\u201320.","DOI":"10.1007\/82_2010_74"},{"issue":"3","key":"10.1016\/j.mehy.2020.109664_b0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00421-007-0506-8","article-title":"Effects of intermittent hypoxic training on cycling performance in well-trained athletes","volume":"101","author":"Roels","year":"2007","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.mehy.2020.109664_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2015.00044","article-title":"Intermittent hypoxia in childhood: the harmful consequences versus potential benefits of therapeutic uses","volume":"3","author":"Serebrovskaya","year":"2015","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.mehy.2020.109664_b0055","article-title":"The protective effects of chronic intermittent hypobaric hypoxia pretreatment against collagen-induced arthritis in rats","volume":"12","author":"Shi","year":"2015","journal-title":"J Inflamm (United Kingdom)"},{"issue":"3","key":"10.1016\/j.mehy.2020.109664_b0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10408363.2012.677947","article-title":"The immunosuppressive molecule HLA-G and its clinical implications","volume":"49","author":"Gonz\u00e1lez","year":"2012","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.mehy.2020.109664_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4587520","article-title":"Hypoxic modulation of HLA-G expression through the metabolic sensor HIF-1 in human cancer cells","volume":"2017","author":"Garziera","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.mehy.2020.109664_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/657625","article-title":"Some basic aspects of HLA-G biology","volume":"2014","author":"Alegre","year":"2014","journal-title":"J Immunol Res"},{"issue":"4952","key":"10.1016\/j.mehy.2020.109664_b0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science (80-)"},{"key":"10.1016\/j.mehy.2020.109664_b0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","article-title":"HLA-G molecules: from maternal-fetal tolerance to tissue acceptance","volume":"81","author":"Carosella","year":"2003","journal-title":"Adv Immunol"},{"issue":"11","key":"10.1016\/j.mehy.2020.109664_b0085","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2020.109664_b0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.186.2.289","article-title":"Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts","volume":"186","author":"Crisa","year":"1997","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.mehy.2020.109664_b0095","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db05-0731","article-title":"The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G","volume":"55","author":"Cirulli","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.mehy.2020.109664_b0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","article-title":"HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels","volume":"55","author":"Hviid","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.mehy.2020.109664_b0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G. An immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol"},{"issue":"4","key":"10.1016\/j.mehy.2020.109664_b0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.humimm.2006.10.016","article-title":"Hypoxia modulates HLA-G gene expression in tumor cells","volume":"68","author":"Mouillot","year":"2007","journal-title":"Hum Immunol"},{"issue":"39","key":"10.1016\/j.mehy.2020.109664_b0115","doi-asserted-by":"crossref","first-page":"63690","DOI":"10.18632\/oncotarget.11628","article-title":"Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2","volume":"7","author":"Yaghi","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.mehy.2020.109664_b0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1095\/biolreprod62.3.739","article-title":"Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line1","volume":"62","author":"Kilburn","year":"2000","journal-title":"Biol Reprod"},{"issue":"4","key":"10.1016\/j.mehy.2020.109664_b0125","article-title":"The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients","volume":"10","author":"Veit","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2020.109664_b0130","article-title":"Introducing a science special issue on mountain ecosystems","author":"Malakoff","year":"2019","journal-title":"Science (80-)"},{"issue":"11","key":"10.1016\/j.mehy.2020.109664_b0135","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.humimm.2010.08.011","article-title":"Increased soluble human leukocyte antigen-G levels in peripheral blood from climbers on Mount Everest","volume":"71","author":"Bourguignon","year":"2010","journal-title":"Hum Immunol"},{"issue":"22","key":"10.1016\/j.mehy.2020.109664_b0140","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Mechanisms of disease: Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"issue":"9903","key":"10.1016\/j.mehy.2020.109664_b0145","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mehy.2020.109664_b0150","first-page":"121","article-title":"Fibroblastos sinoviales","volume":"14","author":"Izquierdo","year":"2013","journal-title":"Semin la Fund Esp Reumatol"},{"issue":"JUN","key":"10.1016\/j.mehy.2020.109664_b0155","article-title":"Hypoxia-Inducible Factor (HIF) as a target for novel therapies in rheumatoid arthritis","volume":"7","author":"Hua","year":"2016","journal-title":"Front Pharmacol"},{"issue":"34","key":"10.1016\/j.mehy.2020.109664_b0160","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.2174\/092986709789760779","article-title":"Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke","volume":"16","author":"Shi","year":"2009","journal-title":"Curr Med Chem"},{"issue":"5748","key":"10.1016\/j.mehy.2020.109664_b0165","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/283666a0","article-title":"Immunisation against heterologous type II collagen induces arthritis in mice [13]","volume":"283","author":"Courtenay","year":"1980","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mehy.2020.109664_b0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.mehy.2020.109664_b0175","article-title":"The smell of hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness","author":"Lacey","year":"2018617","journal-title":"Physiol Rep"},{"issue":"6","key":"10.1016\/j.mehy.2020.109664_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1001881","article-title":"Hypoxia-inducible factor-2\u03b1 is an essential catabolic regulator of inflammatory rheumatoid arthritis","volume":"12","author":"Ryu","year":"2014","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.mehy.2020.109664_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfp193","article-title":"Hypoxia response: A model toxicity pathway for high-throughput screening","volume":"112","author":"Simmons","year":"2009","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1016\/j.mehy.2020.109664_b0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00424-007-0310-7","article-title":"Oxygen and reactive oxygen species in articular cartilage: Modulators of ionic homeostasis","volume":"455","author":"Gibson","year":"2008","journal-title":"Pflugers Arch Eur J Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2020.109664_b0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/BOR.0b013e3282ba5693","article-title":"Hypoxia and osteoarthritis: How chondrocytes survive hypoxic environments","volume":"19","author":"Pfander","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.mehy.2020.109664_b0200","first-page":"1327","article-title":"Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: Putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes","volume":"20","author":"Mobasheri","year":"2005","journal-title":"Histol Histopathol"},{"issue":"5","key":"10.1016\/j.mehy.2020.109664_b0205","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.3390\/ijms15058667","article-title":"Signaling pathways in cartilage repair","volume":"15","author":"Mariani","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.mehy.2020.109664_b0210","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1074\/jbc.M707729200","article-title":"Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways","volume":"283","author":"Lafont","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.mehy.2020.109664_b0215","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/art.37867","article-title":"Hypoxia promotes the production and inhibits the destruction of human articular cartilage","volume":"65","author":"Thoms","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2020.109664_b0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lfs.2015.06.019","article-title":"Andrographolide inhibits the migration, invasion and matrix metalloproteinase expression of rheumatoid arthritis fibroblast-like synoviocytes via inhibition of HIF-1\u03b1 signaling","volume":"136","author":"Li","year":"2015","journal-title":"Life Sci"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720300529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720300529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:20:26Z","timestamp":1759692026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720300529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"alternative-id":["S0306987720300529"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109664","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled hypobaric hypoxia increases immunological tolerance by modifying HLA-G expression, a potential therapy to inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109664"}}